Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1999 Sep;65(3):664–670. doi: 10.1086/302553

Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.

D Campion 1, C Dumanchin 1, D Hannequin 1, B Dubois 1, S Belliard 1, M Puel 1, C Thomas-Anterion 1, A Michon 1, C Martin 1, F Charbonnier 1, G Raux 1, A Camuzat 1, C Penet 1, V Mesnage 1, M Martinez 1, F Clerget-Darpoux 1, A Brice 1, T Frebourg 1
PMCID: PMC1377972  PMID: 10441572

Abstract

To determine the prevalence of early-onset Alzheimer disease (EOAD) and of autosomal dominant forms of EOAD (ADEOAD), we performed a population-based study in the city of Rouen (426,710 residents). EOAD was defined as onset of disease at age <61 years, and ADEOAD was defined as the occurrence of at least three EOAD cases in three generations. Using these stringent criteria, we calculated that the EOAD and ADEOAD prevalences per 100,000 persons at risk were 41.2 and 5.3, respectively. We then performed a mutational analysis of the genes for amyloid precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2) in 34 families with ADEOAD ascertained in France. In 19 (56%) of these families, we identified 16 distinct PSEN1 missense mutations, including 4 (Thr147Ile, Trp165Cys, Leu173Trp, and Ser390Ile) not reported elsewhere. APP mutations, including a novel mutation located at codon 715, were identified in 5 (15%) of the families. In the 10 remaining ADEOAD families and in 9 additional autosomal dominant Alzheimer disease families that did not fulfill the strict criteria for ADEOAD, no PSEN1, PSEN2, or APP mutation was identified. These results show that (1) PSEN1 and APP mutations account for 71% of ADEOAD families and (2) nonpenetrance at age <61 years is probably infrequent for PSEN1 or APP mutations.

Full Text

The Full Text of this article is available as a PDF (224.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldudo J., Bullido M. J., Arbizu T., Oliva R., Valdivieso F. Identification of a novel mutation (Leu282Arg) of the human presenilin 1 gene in Alzheimer's disease. Neurosci Lett. 1998 Jan 16;240(3):174–176. doi: 10.1016/s0304-3940(97)00950-6. [DOI] [PubMed] [Google Scholar]
  2. Ancolio K., Dumanchin C., Barelli H., Warter J. M., Brice A., Campion D., Frébourg T., Checler F. Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val-715 --> Met betaAPP-770 mutation responsible for probable early-onset Alzheimer's disease. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):4119–4124. doi: 10.1073/pnas.96.7.4119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aoki M., Abe K., Oda N., Ikeda M., Tsuda T., Kanai M., Shoji M., St George-Hyslop P. H., Itoyama Y. A presenilin-1 mutation in a Japanese family with Alzheimer's disease and distinctive abnormalities on cranial MRI. Neurology. 1997 Apr;48(4):1118–1120. doi: 10.1212/wnl.48.4.1118. [DOI] [PubMed] [Google Scholar]
  4. Axelman K., Basun H., Lannfelt L. Wide range of disease onset in a family with Alzheimer disease and a His163Tyr mutation in the presenilin-1 gene. Arch Neurol. 1998 May;55(5):698–702. doi: 10.1001/archneur.55.5.698. [DOI] [PubMed] [Google Scholar]
  5. Campion D., Brice A., Hannequin D., Charbonnier F., Dubois B., Martin C., Michon A., Penet C., Bellis M., Calenda A. No founder effect in three novel Alzheimer's disease families with APP 717 Val-->Ile mutation. Clerget-darpoux. French Alzheimer's Disease Study Group. J Med Genet. 1996 Aug;33(8):661–664. doi: 10.1136/jmg.33.8.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Campion D., Brice A., Hannequin D., Tardieu S., Dubois B., Calenda A., Brun E., Penet C., Tayot J., Martinez M. A large pedigree with early-onset Alzheimer's disease: clinical, neuropathologic, and genetic characterization. Neurology. 1995 Jan;45(1):80–85. doi: 10.1212/wnl.45.1.80. [DOI] [PubMed] [Google Scholar]
  7. Campion D., Flaman J. M., Brice A., Hannequin D., Dubois B., Martin C., Moreau V., Charbonnier F., Didierjean O., Tardieu S. Mutations of the presenilin I gene in families with early-onset Alzheimer's disease. Hum Mol Genet. 1995 Dec;4(12):2373–2377. doi: 10.1093/hmg/4.12.2373. [DOI] [PubMed] [Google Scholar]
  8. Campion D., Martinez M., Hannequin D., Brice A., Thomas-Anterion C., Michon A., Babron M. C., Dubois B., Goas Y., Jaillard-Serradt A. Characteristics of familial aggregation in early-onset Alzheimer's disease: evidence of subgroups. Am J Med Genet. 1995 Jun 19;60(3):221–227. doi: 10.1002/ajmg.1320600310. [DOI] [PubMed] [Google Scholar]
  9. Crook R., Ellis R., Shanks M., Thal L. J., Perez-Tur J., Baker M., Hutton M., Haltia T., Hardy J., Galasko D. Early-onset Alzheimer's disease with a presenilin-1 mutation at the site corresponding to the Volga German presenilin-2 mutation. Ann Neurol. 1997 Jul;42(1):124–128. doi: 10.1002/ana.410420121. [DOI] [PubMed] [Google Scholar]
  10. Crook R., Verkkoniemi A., Perez-Tur J., Mehta N., Baker M., Houlden H., Farrer M., Hutton M., Lincoln S., Hardy J. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med. 1998 Apr;4(4):452–455. doi: 10.1038/nm0498-452. [DOI] [PubMed] [Google Scholar]
  11. Cruts M., Backhovens H., Wang S. Y., Van Gassen G., Theuns J., De Jonghe C. D., Wehnert A., De Voecht J., De Winter G., Cras P. Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3. Hum Mol Genet. 1995 Dec;4(12):2363–2371. doi: 10.1093/hmg/4.12.2363. [DOI] [PubMed] [Google Scholar]
  12. Cruts M., van Duijn C. M., Backhovens H., Van den Broeck M., Wehnert A., Serneels S., Sherrington R., Hutton M., Hardy J., St George-Hyslop P. H. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet. 1998 Jan;7(1):43–51. doi: 10.1093/hmg/7.1.43. [DOI] [PubMed] [Google Scholar]
  13. Dermaut B., Cruts M., Slooter A. J., Van Gestel S., De Jonghe C., Vanderstichele H., Vanmechelen E., Breteler M. M., Hofman A., van Duijn C. M. The Glu318Gly substitution in presenilin 1 is not causally related to Alzheimer disease. Am J Hum Genet. 1999 Jan;64(1):290–292. doi: 10.1086/302200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dumanchin C., Brice A., Campion D., Hannequin D., Martin C., Moreau V., Agid Y., Martinez M., Clerget-Darpoux F., Frebourg T. De novo presenilin 1 mutations are rare in clinically sporadic, early onset Alzheimer's disease cases. French Alzheimer's Disease Study Group. J Med Genet. 1998 Aug;35(8):672–673. doi: 10.1136/jmg.35.8.672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Farrer L. A., Cupples L. A., van Duijn C. M., Kurz A., Zimmer R., Müller U., Green R. C., Clarke V., Shoffner J., Wallace D. C. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives. Ann Neurol. 1995 Nov;38(5):797–808. doi: 10.1002/ana.410380515. [DOI] [PubMed] [Google Scholar]
  16. Fidani L., Rooke K., Chartier-Harlin M. C., Hughes D., Tanzi R., Mullan M., Roques P., Rossor M., Hardy J., Goate A. Screening for mutations in the open reading frame and promoter of the beta-amyloid precursor protein gene in familial Alzheimer's disease: identification of a further family with APP717 Val-->Ile. Hum Mol Genet. 1992 Jun;1(3):165–168. doi: 10.1093/hmg/1.3.165. [DOI] [PubMed] [Google Scholar]
  17. Forsell C., Froelich S., Axelman K., Vestling M., Cowburn R. F., Lilius L., Johnston J. A., Engvall B., Johansson K., Dahlkild A. A novel pathogenic mutation (Leu262Phe) found in the presenilin 1 gene in early-onset Alzheimer's disease. Neurosci Lett. 1997 Sep 26;234(1):3–6. doi: 10.1016/s0304-3940(97)00603-4. [DOI] [PubMed] [Google Scholar]
  18. Fox N. C., Kennedy A. M., Harvey R. J., Lantos P. L., Roques P. K., Collinge J., Hardy J., Hutton M., Stevens J. M., Warrington E. K. Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor. Brain. 1997 Mar;120(Pt 3):491–501. doi: 10.1093/brain/120.3.491. [DOI] [PubMed] [Google Scholar]
  19. Gómez-Isla T., Wasco W., Pettingell W. P., Gurubhagavatula S., Schmidt S. D., Jondro P. D., McNamara M., Rodes L. A., DiBlasi T., Growdon W. B. A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes. Ann Neurol. 1997 Jun;41(6):809–813. doi: 10.1002/ana.410410618. [DOI] [PubMed] [Google Scholar]
  20. Harvey R. J., Ellison D., Hardy J., Hutton M., Roques P. K., Collinge J., Fox N. C., Rossor M. N. Chromosome 14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine-->serine (L250S) substitution at codon 250 of the presenilin 1 gene. J Neurol Neurosurg Psychiatry. 1998 Jan;64(1):44–49. doi: 10.1136/jnnp.64.1.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hixson J. E., Vernier D. T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990 Mar;31(3):545–548. [PubMed] [Google Scholar]
  22. Hutton M., Hardy J. The presenilins and Alzheimer's disease. Hum Mol Genet. 1997;6(10):1639–1646. doi: 10.1093/hmg/6.10.1639. [DOI] [PubMed] [Google Scholar]
  23. Kokmen E., Beard C. M., Offord K. P., Kurland L. T. Prevalence of medically diagnosed dementia in a defined United States population: Rochester, Minnesota, January 1, 1975. Neurology. 1989 Jun;39(6):773–776. doi: 10.1212/wnl.39.6.773. [DOI] [PubMed] [Google Scholar]
  24. Kwok J. B., Taddei K., Hallupp M., Fisher C., Brooks W. S., Broe G. A., Hardy J., Fulham M. J., Nicholson G. A., Stell R. Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. Neuroreport. 1997 Apr 14;8(6):1537–1542. doi: 10.1097/00001756-199704140-00043. [DOI] [PubMed] [Google Scholar]
  25. Lendon C. L., Ashall F., Goate A. M. Exploring the etiology of Alzheimer disease using molecular genetics. JAMA. 1997 Mar 12;277(10):825–831. [PubMed] [Google Scholar]
  26. Lendon C. L., Martinez A., Behrens I. M., Kosik K. S., Madrigal L., Norton J., Neuman R., Myers A., Busfield F., Wragg M. E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles. Hum Mutat. 1997;10(3):186–195. doi: 10.1002/(SICI)1098-1004(1997)10:3<186::AID-HUMU2>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
  27. Martinez M., Campion D., Brice A., Hannequin D., Dubois B., Didierjean O., Michon A., Thomas-Anterion C., Puel M., Frebourg T. Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease. Arch Neurol. 1998 Jun;55(6):810–816. doi: 10.1001/archneur.55.6.810. [DOI] [PubMed] [Google Scholar]
  28. Mattila K. M., Forsell C., Pirttilä T., Rinne J. O., Lehtimäki T., Röyttä M., Lilius L., Eerola A., St George-Hyslop P. H., Frey H. The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease. Ann Neurol. 1998 Dec;44(6):965–967. doi: 10.1002/ana.410440617. [DOI] [PubMed] [Google Scholar]
  29. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
  30. Perez-Tur J., Froelich S., Prihar G., Crook R., Baker M., Duff K., Wragg M., Busfield F., Lendon C., Clark R. F. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport. 1995 Dec 29;7(1):297–301. [PubMed] [Google Scholar]
  31. Poorkaj P., Sharma V., Anderson L., Nemens E., Alonso M. E., Orr H., White J., Heston L., Bird T. D., Schellenberg G. D. Missense mutations in the chromosome 14 familial Alzheimer's disease presenilin 1 gene. Hum Mutat. 1998;11(3):216–221. doi: 10.1002/(SICI)1098-1004(1998)11:3<216::AID-HUMU6>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  32. Pérez-Tur J., Campion D., Martinez M., Brice A., Tardieu S., Hannequin D., Agid Y., Delacourte A., Clerget-Darpoux F., Chartier-Harlin M. C. Evidence for apolipoprotein E epsilon 4 association in early-onset Alzheimer's patients with late-onset relatives. Am J Med Genet. 1995 Dec 18;60(6):550–553. doi: 10.1002/ajmg.1320600613. [DOI] [PubMed] [Google Scholar]
  33. Rossor M. N., Fox N. C., Beck J., Campbell T. C., Collinge J. Incomplete penetrance of familial Alzheimer's disease in a pedigree with a novel presenilin-1 gene mutation. Lancet. 1996 Jun 1;347(9014):1560–1560. doi: 10.1016/s0140-6736(96)90715-1. [DOI] [PubMed] [Google Scholar]
  34. Sandbrink R., Zhang D., Schaeffer S., Masters C. L., Bauer J., Förstl H., Beyreuther K. Missense mutations of the PS-1/S182 gene in German early-onset Alzheimer's disease patients. Ann Neurol. 1996 Aug;40(2):265–266. doi: 10.1002/ana.410400225. [DOI] [PubMed] [Google Scholar]
  35. Schoenberg B. S., Anderson D. W., Haerer A. F. Severe dementia. Prevalence and clinical features in a biracial US population. Arch Neurol. 1985 Aug;42(8):740–743. doi: 10.1001/archneur.1985.04210090004002. [DOI] [PubMed] [Google Scholar]
  36. Sherrington R., Froelich S., Sorbi S., Campion D., Chi H., Rogaeva E. A., Levesque G., Rogaev E. I., Lin C., Liang Y. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet. 1996 Jul;5(7):985–988. doi: 10.1093/hmg/5.7.985. [DOI] [PubMed] [Google Scholar]
  37. Sulkava R., Wikström J., Aromaa A., Raitasalo R., Lehtinen V., Lahtela K., Palo J. Prevalence of severe dementia in Finland. Neurology. 1985 Jul;35(7):1025–1029. doi: 10.1212/wnl.35.7.1025. [DOI] [PubMed] [Google Scholar]
  38. Tysoe C., Whittaker J., Xuereb J., Cairns N. J., Cruts M., Van Broeckhoven C., Wilcock G., Rubinsztein D. C. A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease. Am J Hum Genet. 1998 Jan;62(1):70–76. doi: 10.1086/301672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Wisniewski T., Dowjat W. K., Buxbaum J. D., Khorkova O., Efthimiopoulos S., Kulczycki J., Lojkowska W., Wegiel J., Wisniewski H. M., Frangione B. A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years. Neuroreport. 1998 Jan 26;9(2):217–221. doi: 10.1097/00001756-199801260-00008. [DOI] [PubMed] [Google Scholar]
  40. Yasuda M., Maeda K., Ikejiri Y., Kawamata T., Kuroda S., Tanaka C. A novel missense mutation in the presenilin-1 gene in a familial Alzheimer's disease pedigree with abundant amyloid angiopathy. Neurosci Lett. 1997 Aug 22;232(1):29–32. doi: 10.1016/s0304-3940(97)00569-7. [DOI] [PubMed] [Google Scholar]
  41. van Duijn C. M., de Knijff P., Cruts M., Wehnert A., Havekes L. M., Hofman A., Van Broeckhoven C. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet. 1994 May;7(1):74–78. doi: 10.1038/ng0594-74. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES